Yuan‐Ching Chang

2.4k total citations
52 papers, 1.4k citations indexed

About

Yuan‐Ching Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuan‐Ching Chang has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Yuan‐Ching Chang's work include Regulation of Appetite and Obesity (6 papers), Breast Cancer Treatment Studies (6 papers) and International Development and Aid (6 papers). Yuan‐Ching Chang is often cited by papers focused on Regulation of Appetite and Obesity (6 papers), Breast Cancer Treatment Studies (6 papers) and International Development and Aid (6 papers). Yuan‐Ching Chang collaborates with scholars based in Taiwan, United States and Switzerland. Yuan‐Ching Chang's co-authors include Shih‐Ping Cheng, Chien‐Liang Liu, Tsang‐Pai Liu, Chiachen Chen, Solomon W. Polachek, Ing-Cherng Guo, John Robst, King‐Jen Chang, Chien‐Liang Liu and Jie‐Jen Lee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Applied Physics.

In The Last Decade

Yuan‐Ching Chang

50 papers receiving 1.3k citations

Peers

Yuan‐Ching Chang

ONCOL

EPIDE

PRM

Barry Hoffman Canada

Brian K. Rivera United States

Mary Anne Rossing United States

Toral Gathani United Kingdom

Lindsay L. Peterson United States

Brandy M. Heckman‐Stoddard United States

Georg Pfeiler Austria

Rosa Divella Italy

Jarosław Skokowski Poland

C Torrance United Kingdom

Barry Hoffman Canada

Yuan‐Ching Chang

545 ×1.5

ONCOL

519 ×1.7

244 ×0.9

109 ×0.6

EPIDE

127 ×0.7

PRM

Citations per year, relative to Yuan‐Ching Chang Yuan‐Ching Chang (= 1×) peers Barry Hoffman

Countries citing papers authored by Yuan‐Ching Chang

Since Specialization

Citations

This map shows the geographic impact of Yuan‐Ching Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Ching Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Ching Chang more than expected).

Fields of papers citing papers by Yuan‐Ching Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan‐Ching Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Ching Chang. The network helps show where Yuan‐Ching Chang may publish in the future.

Co-authorship network of co-authors of Yuan‐Ching Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan‐Ching Chang. A scholar is included among the top collaborators of Yuan‐Ching Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan‐Ching Chang. Yuan‐Ching Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Yi‐Chung, et al.. (2024). Psychometric Evaluation of the Chinese Version of the Vulvovaginal Symptom Questionnaire in Women With Breast Cancer. Journal of Advanced Nursing. 81(7). 3904–3928.

Kok, Victor C., et al.. (2024). Select gene mutations associated with survival outcomes in ER‐positive ERBB2‐negative early‐stage invasive breast cancer: A single‐institutional tissue bank study. Cancer Medicine. 13(14). e70035–e70035. 2 indexed citations

Hsu, Yi‐Chiung, et al.. (2024). Role of Epstein-Barr Virus in Breast Cancer: Correlation with Clinical Outcome and Survival Analysis. Journal of Cancer. 15(8). 2403–2411. 2 indexed citations

Liu, Chien‐Liang, Shih‐Ping Cheng, Wen-Chien Huang, et al.. (2023). Aberrant Expression of Solute Carrier Family 35 Member A2 Correlates With Tumor Progression in Breast Cancer. In Vivo. 37(1). 262–269. 7 indexed citations

Liu, Chien‐Liang, Wen‐Chien Huang, Shih‐Ping Cheng, et al.. (2023). Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice. Current Issues in Molecular Biology. 45(6). 4518–4528. 2 indexed citations

Ko, Ellen Wen-Ching, et al.. (2023). Unraveling the connections between gut microbiota, stress, and quality of life for holistic care in newly diagnosed breast cancer patients. Scientific Reports. 13(1). 17916–17916. 10 indexed citations

Huober, Jens, Carlos H. Barrios, Naoki Niikura, et al.. (2022). Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial. Journal of Clinical Oncology. 40(25). 2946–2956. 82 indexed citations

Hickish, Tamas, Ajay Mehta, Mei-Ching Liu, et al.. (2022). Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial. Breast Cancer Research and Treatment. 192(3). 593–602. 9 indexed citations

Lin, Jiunn-Chang, Chien‐Liang Liu, Yuan‐Ching Chang, et al.. (2021). Trilostane, a 3β-hydroxysteroid dehydrogenase inhibitor, suppresses growth of hepatocellular carcinoma and enhances anti-cancer effects of sorafenib. Investigational New Drugs. 39(6). 1493–1506. 6 indexed citations

10.

Lin, Chi‐Hsin, Yuan‐Ching Chang, Ting‐Kuo Chang, et al.. (2020). Enhanced expression of coxsackievirus and adenovirus receptor in lipopolysaccharide-induced inflammatory macrophages is through TRIF-dependent innate immunity pathway. Life Sciences. 265. 118832–118832. 3 indexed citations

11.

Liu, Chien‐Liang, Ming‐Jen Chen, Jiunn-Chang Lin, et al.. (2019). Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC Pathway. Journal of Breast Cancer. 22(2). 185–185. 36 indexed citations

12.

Chang, Yuan‐Ching, Chi‐Hsin Lin, Jiunn-Chang Lin, et al.. (2019). Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 1 Suppresses Interleukin-6 in Breast Cancer. Journal of Surgical Research. 241. 8–14. 4 indexed citations

13.

Liu, Chien‐Liang, Po‐Sheng Yang, Ming-Nan Chien, et al.. (2018). Expression of serine peptidase inhibitor Kunitz type 1 in differentiated thyroid cancer. Histochemistry and Cell Biology. 149(6). 635–644. 13 indexed citations

14.

Chen, I‐Chun, Yuan‐Ching Chang, Yen‐Shen Lu, et al.. (2016). Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer. Scientific Reports. 6(1). 21374–21374. 22 indexed citations

15.

Chang, Yuan‐Ching, et al.. (2015). Bowen's Disease of the Nipple in a Woman with Tongue Cancer. SHILAP Revista de lepidopterología. 1 indexed citations

16.

Chen, Ming‐Jen, et al.. (2010). Adhesional Small-bowel Obstruction in the Absence of Previous Abdominal Operations. International journal of gerontology. 4(4). 202–204. 2 indexed citations

17.

Chen, Chiachen, Yuan‐Ching Chang, Chien‐Liang Liu, et al.. (2007). Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Endocrine Related Cancer. 14(2). 513–529. 75 indexed citations

18.

Liu, Chien‐Liang, Yuan‐Ching Chang, Shih‐Ping Cheng, et al.. (2007). The Roles of Serum Leptin Concentration and Polymorphism in Leptin Receptor Gene at Codon 109 in Breast Cancer. Oncology. 72(1-2). 75–81. 64 indexed citations

19.

Liu, Chien‐Liang, Jon‐Kway Huang, Shih‐Ping Cheng, et al.. (2006). Fatty liver and transaminase changes with adjuvant tamoxifen therapy. Anti-Cancer Drugs. 17(6). 709–713. 34 indexed citations

20.

Polachek, Solomon W., John Robst, & Yuan‐Ching Chang. (1999). Liberalism and Interdependence: Extending the Trade-Conflict Model. Journal of Peace Research. 36(4). 405–422. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact